Effectiveness of Subcutaneously Administered Leuprolide Acetate to Achieve Low Nadir Testosterone in Prostate Cancer Patients

Evidence suggests lower nadir testosterone levels during the first year of androgen deprivation therapy improve advanced prostate cancer clinical outcomes. We evaluated pivotal trials for subcutaneously administered leuprolide acetate (1-, 3-, 4-, and 6-month doses) to determine nadir testosterone l...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Rev Urol
Main Authors: Pieczonka, Christopher M., Twardowski, Przemyslaw, Renzulli, Joseph, Hafron, Jason, Boldt-Houle, Deborah M., Atkinson, Stuart, Eggener, Scott
Formato: Artigo
Idioma:Inglês
Publicado: MedReviews, LLC 2018
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6168320/
https://ncbi.nlm.nih.gov/pubmed/30288142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3909/riu0798
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares